Applied Therapeutics (APLT) Insider Trading & Ownership → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free APLT Stock Alerts $4.28 +0.05 (+1.18%) (As of 04/26/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Applied Therapeutics (NASDAQ:APLT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage19.10%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$65,400.00Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$3.44 M Get APLT Insider Trade Alerts Want to know when executives and insiders are buying or selling Applied Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address APLT Insider Buying and Selling by Quarter Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. Applied Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/14/2024Leslie D FuntleyderCFOSell28,727$5.39$154,838.53 3/14/2024Riccardo PerfettiInsiderSell110,804$5.39$597,233.56 3/14/2024Shoshana ShendelmanCEOSell318,573$5.39$1,717,108.47 12/1/2023Stacy J KanterDirectorBuy30,000$2.18$65,400.00 11/30/2023Riccardo PerfettiInsiderSell1,583$1.97$3,118.51 11/30/2023Shoshana ShendelmanCEOSell3,968$1.97$7,816.96 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/2/2023Real Estate Equitie AlexandriaMajor ShareholderSell103,808$2.32$240,834.56 10/31/2023Real Estate Equitie AlexandriaMajor ShareholderSell155,000$2.41$373,550.00 9/27/2023Riccardo PerfettiInsiderSell10,932$2.70$29,516.40 9/27/2023Shoshana ShendelmanCEOSell115,632$2.70$312,206.40 (Data available from 1/1/2013 forward) APLT Insider Trading Activity - Frequently Asked Questions Who is on Applied Therapeutics's Insider Roster? The list of insiders at Applied Therapeutics includes Charles Silberstein, Chids Mahadevan, Leslie D Funtleyder, Real Estate Equitie Alexandria, Riccardo Perfetti, Shoshana Shendelman, and Stacy J Kanter. Learn more on insiders at APLT. What percentage of Applied Therapeutics stock is owned by insiders? 19.10% of Applied Therapeutics stock is owned by insiders. Learn more on APLT's insider holdings. Which Applied Therapeutics insiders have been buying company stock? The following insiders have purchased APLT shares in the last 24 months: Real Estate Equitie Alexandria ($3,500,000.00), Shoshana Shendelman ($52,339.56), and Stacy J Kanter ($65,400.00). How much insider buying is happening at Applied Therapeutics? Insiders have purchased a total of 3,618,153 APLT shares in the last 24 months for a total of $3,617,739.56 bought. Which Applied Therapeutics insiders have been selling company stock? The following insiders have sold APLT shares in the last 24 months: Chids Mahadevan ($1,493.25), Leslie D Funtleyder ($154,838.53), Real Estate Equitie Alexandria ($614,384.56), Riccardo Perfetti ($635,376.70), and Shoshana Shendelman ($2,051,573.53). How much insider selling is happening at Applied Therapeutics? Insiders have sold a total of 871,855 Applied Therapeutics shares in the last 24 months for a total of $3,457,666.57 sold. More Insider Trading Tools from MarketBeat Related Companies: COMPASS Pathways Insider Trades IGM Biosciences Insider Trades Altimmune Insider Trades ArriVent BioPharma Insider Trades Phibro Animal Health Insider Trades AnaptysBio Insider Trades Acelyrin Insider Trades Phathom Pharmaceuticals Insider Trades Korro Bio Insider Trades KalVista Pharmaceuticals Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:APLT) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
